Several vaccinia virus (VV)-varicella-zoster virus (VZV) recombinants expressing glycoprotein I (gpI) of VZV were isolated from the Prague strain of VV. One of these, v46, was inoculated intraperitoneally into mice. Groups of mice were bled 4 and 8 weeks later and their sera were examined for anti-VZV and anti-VV antibodies by ELISA. At 4 weeks, all mice inoculated with the three largest virus doses (107, 106 and 105 p.f.u.), and at 8 weeks all mice inoculated with the four highest virus doses (107, 106, 105 and 104 p.f.u.), had developed both anti-VV and anti-VZV antibodies. Antibodies were also detected in a high proportion of mice infected with lower doses of virus and in some instances VZV antibodies were present in the absence of VV antibodies. None of the animals inoculated in parallel with either a thymidine kinase-negative mutant of the original VV or diluent alone developed antibody reactive with VZV. The specificity of the reaction was assessed further by Western blotting using anti-gpI monoclonal antibodies as a positive control. Sera from animals immunized with v46 possessed antibody capable of neutralizing extracellular VZV in the presence of complement.
ArvinA. M.,
Kinney-ThomasE.,
ShriverK.,
GroseC.,
KoropchakC.,
ScrantonE.,
WitekA. E.,
DiazP. S.1986; Immunity to varicella-zoster viral glycoproteins, gpI (gp90/58) and gpIII (gp 118), and to a nonglycolysated protein, pl70. Journal of Immunology 137:134–1351
BrunellP. A.,
NovelliV. M.,
KellerP. M.,
EllisR. W.1987; Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response. Journal of Infectious Diseases 156:430–435
CabiracG.,
GildenD.,
WellishM.,
VafaiA.1988; Expression of varicella-zoster virus glycoprotein I in cells infected with a vaccinia virus recombinant. Virus Research 10:205–213
DiazP. S.,
SmithS.,
HunterE.,
ArvinA. M.1988; Immunity to whole varicella-zoster virus antigen and glycoproteins I and pi70: relation to the immunizing regimen of live attenuated varicella vaccine. Journal of Infectious Diseases 158:1245–1252
DubeyL.,
SteinbergS. P.,
La RussaP.,
OhP.,
GershonA.1988; Western blot analysis of antibody to varicella-zoster virus. Journal of Infectious Diseases 157:882–888
GroseC.1989; Congenital varicella-zoster infection and the failure to establish virus-specific cell-mediated immunity. Molecular Biology and Medicine 6:453–462
KellerP. M.,
NeffB. J.,
EllisR. W.1984; Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. Journal of Virology 52:293–297
MontalvoE. A.,
GroseC.1986; Varicella-zoster virus glycoprotein gpl is selectively phosphorylated by a virus-induced protein kinase. Proceedings of the National Academy of Sciences, U,. S,. A 83:8967–8971
SlonimD.,
HulenováM.1969; Study of plaque titration of vaccinia virus in chick embryo cell cultures. I. Assays under an agar overlay. Acta virologica 13:209–215
SoikeK. F.,
KellerP. M.,
EllisR. W.1987; Immunization of monkeys with varicella-zoster virus glycoprotein antigens and their response to challenge with simian varicella virus. Journal of Medical Virology 22:307–313
VafaiA.,
WroblewskaZ.,
MahalingamR.,
CabiracG.,
WellishM.,
CiscoM.,
GildenD.1988; Recognition of similar epitopes on varicella-zoster virus gpl and gpIV by mono clonal antibodies. Journal of Virology 62:2544–2551